130 related articles for article (PubMed ID: 1700402)
1. [Evaluation of the treatment of chronic active hepatitis (HBsAg+) with isoprinosine. II. Immunological studies].
Dabrowska-Bernstein B; Stasiak A; Dabrowski M; Pawińska A; Cianciara J; Loch T; Babiuch L
Pol Tyg Lek; 1990 Apr 16-30; 45(16-18):347-51. PubMed ID: 1700402
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of chronic active hepatitis (HBsAg +,HBeAg +) with isoprinosine. Clinical evaluation].
Cianciara J; Loch T; Babiuch L; Dabrowska-Bernstein B; Stasiak A; Dabrowski M; Pawińska A
Pol Tyg Lek; 1988 Sep; 43(37):1195-8. PubMed ID: 2470069
[No Abstract] [Full Text] [Related]
3. [Markers of chronic hepatitis B in children after completion of therapy with isoprinosine].
Kowalik-Mikołajewska B; Barszcz T; Ladyzyńska E; Wojnarowski M
Pol Tyg Lek; 1993 Mar 15-29; 48(11-13):263-4. PubMed ID: 7694263
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the effectiveness of isoprinosine in the treatment of patients with acute viral hepatitis. II. Immunological evaluation].
Nedoszytko B; Michalska Z; Dubicka M; Gajda A
Wiad Lek; 1987 Nov; 40(21):1469-74. PubMed ID: 2453975
[No Abstract] [Full Text] [Related]
5. [Course of chronic virus hepatitis B in children and attempts at modifying its treatment].
Kowalik-Mikołajewska B
Pol Tyg Lek; 1993 Mar 15-29; 48(11-13):258-60. PubMed ID: 7694262
[TBL] [Abstract][Full Text] [Related]
6. Isoprinosine in the treatment of chronic active hepatitis type B.
Cianciara J; Laskus T; Gabinska E; Loch T
Scand J Infect Dis; 1990; 22(6):645-8. PubMed ID: 1704640
[TBL] [Abstract][Full Text] [Related]
7. [Immunocorrective therapy of patients with chronic active liver diseases of a viral nature].
Mansurov KhKh; Asfandiiarova NS; Nikolaeva OS; Mansurova FKh; Rasunova TKh
Ter Arkh; 1987; 59(2):114-7. PubMed ID: 3495044
[TBL] [Abstract][Full Text] [Related]
8. Thymostimulin in the treatment of hepatitis B surface antigen-positive chronic active hepatitis. Controlled clinical trial--two years follow-up.
Romeo F; Palmisano L; Arcoria D
Arzneimittelforschung; 1987 Apr; 37(4):450-6. PubMed ID: 3300664
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the effectiveness of isoprinosine in the treatment of patients with acute viral hepatitis. I. Clinical evaluation].
Michalska Z; Dubicka M; Nedoszytko B; Gajda A
Wiad Lek; 1987 Oct; 40(20):1369-74. PubMed ID: 2451357
[No Abstract] [Full Text] [Related]
10. Treatment with thymic extract TFX for chronic active hepatitis B.
Dworniak D; Tchórzewski H; Pokoca L; Tkacz B; Drobnik S; Baj Z; Luciak M
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):537-47. PubMed ID: 1841551
[TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa). Evaluation of the efficiency of cellular mechanisms of the immunologic response].
Dabrowska-Bernstein BK; Dabrowski MP; Stasiak A; Wasowska B; Brzosko WJ
Pol Tyg Lek; 1984 Aug; 39(33):1091-6. PubMed ID: 6334280
[No Abstract] [Full Text] [Related]
12. [Evaluation of clinical effectiveness of colchicine in the treatment of chronic active hepatitis with transformation to liver cirrhosis].
Simon K; Gładysz A; Zalewska M; Machaj A
Przegl Epidemiol; 1991; 45(4):331-4. PubMed ID: 1841412
[TBL] [Abstract][Full Text] [Related]
13. Active rosette-forming lymphocytes in chronic hepatitis.
Stanciu L; Urcan S; Părău N; Radu D; Popescu S
Med Interne; 1982; 20(4):277-82. PubMed ID: 6985551
[TBL] [Abstract][Full Text] [Related]
14. [Effect of dimephosphon on the clinico-immunological indicators in children with chronic hepatitis].
Gorbunova IV; Shabunina EI; Maianskaia IV; Studentsova IA
Pediatriia; 1991; (10):111-2. PubMed ID: 1787992
[No Abstract] [Full Text] [Related]
15. Immunotherapy of chronic active viral hepatitis B with propionibacterium granulosum.
Gil J; Ziemka J; Brzosko WJ; Dabrowski M; Dabrowska-Bernstein B; Szmigielski S; Ko HL; Jeljaszewicz J; Pulverer G
Hepatogastroenterology; 1984 Jun; 31(3):109-18. PubMed ID: 6205967
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of different types of treatments in chronic active hepatitis.
Bahgat MH; Sabbour MS; Osman LM; Ghali AF; Gadallah MA
Chemioterapia; 1985 Jun; 4(3):227-35. PubMed ID: 2411437
[TBL] [Abstract][Full Text] [Related]
17. [Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?].
Maier KP; Lepiorz H; Berthold H; Gerok W
Leber Magen Darm; 1982 Aug; 12(4):150-3. PubMed ID: 7132529
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study of the use of isoprinosine in viral infections].
Fiori GP
G Ital Chemioter; 1981; 28(1-2):73-6. PubMed ID: 6182051
[No Abstract] [Full Text] [Related]
19. The immunoenhancing effect of cianidanol (C) on macrophages and on the T-cell system.
Rauch G
Methods Find Exp Clin Pharmacol; 1986 Mar; 8(3):147-50. PubMed ID: 3487015
[TBL] [Abstract][Full Text] [Related]
20. [Immune modulating effect of isoprinosine in patients with post-alcoholic liver cirrhosis].
Boroń-Kaczmarska A; Boroń P; Puch U; Hryniewicz A; Bobrowska E
Z Gesamte Inn Med; 1990 May; 45(10):294-6. PubMed ID: 1697438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
